These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9565715)

  • 21. Efficacy and pharmacokinetics of fluvoxamine maleate in patients with mild depression undergoing hemodialysis.
    Kamo T; Horikawa N; Tsuruta Y; Miyasita M; Hatakeyama H; Maebashi Y
    Psychiatry Clin Neurosci; 2004 Apr; 58(2):133-7. PubMed ID: 15009816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers.
    Covi L; Hess JM; Kreiter NA; Haertzen CA
    Am J Drug Alcohol Abuse; 1995 Aug; 21(3):327-44. PubMed ID: 7484983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
    Cornelius JR; Salloum IM; Haskett RF; Daley DC; Cornelius MD; Thase ME; Perel JM
    Addict Behav; 2000; 25(2):307-10. PubMed ID: 10795957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
    Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
    Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
    Wehmeier PM; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann RW; Gattaz WF
    Pharmacopsychiatry; 2005 Jan; 38(1):13-6. PubMed ID: 15706460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sociodemographic predictors of response to antidepressant treatment.
    Spillmann M; Borus JS; Davidson KG; Worthington JJ; Tedlow JR; Fava M
    Int J Psychiatry Med; 1997; 27(2):129-36. PubMed ID: 9565719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents.
    Nilsson M; Joliat MJ; Miner CM; Brown EB; Heiligenstein JH
    J Child Adolesc Psychopharmacol; 2004; 14(3):412-7. PubMed ID: 15650497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
    Emslie GJ; Wells TG; Prakash A; Zhang Q; Pangallo BA; Bangs ME; March JS
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):293-305. PubMed ID: 25978741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to nefazodone in a depressed patient with end-stage renal disease.
    Seabolt JL; De León OA
    Gen Hosp Psychiatry; 2001; 23(1):45-6. PubMed ID: 11291641
    [No Abstract]   [Full Text] [Related]  

  • 33. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity.
    Pillay SS; Renshaw PF; Bonello CM; Lafer BC; Fava M; Yurgelun-Todd D
    Psychiatry Res; 1998 Dec; 84(2-3):61-74. PubMed ID: 10710164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
    Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
    J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review.
    Martinotti G; Sepede G; Signorelli M; Aguglia E; Di Giannantonio M
    Expert Opin Pharmacother; 2013 Jun; 14(8):1065-75. PubMed ID: 23527943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial.
    Zhang WJ; Yang XB; Zhong BL
    J Altern Complement Med; 2009 Aug; 15(8):837-44. PubMed ID: 19678773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Problem-solving ability and comorbid personality disorders in depressed outpatients.
    Harley R; Petersen T; Scalia M; Papakostas GI; Farabaugh A; Fava M
    Depress Anxiety; 2006; 23(8):496-501. PubMed ID: 16845662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.